Lactate dehydrogenase (LDH) reinforcement in predicting Covid-19 patient’s outcomes
H. Eid (Beirut, Lebanon), A. El Kik (Beirut, Lebanon), A. Riachy (Beirut, Lebanon), E. Mekhael (Beirut, Lebanon), K. Hoyek (Beirut, Lebanon), N. Nassim (Beirut, Lebanon), G. Khayat (Beirut, Lebanon), G. Sleilaty (Beirut, Lebanon), M. Riachy (Beirut, Lebanon)
Source: International Congress 2022 – Biomarkers in COVID
Session: Biomarkers in COVID
Session type: Thematic Poster
Number: 349
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Eid (Beirut, Lebanon), A. El Kik (Beirut, Lebanon), A. Riachy (Beirut, Lebanon), E. Mekhael (Beirut, Lebanon), K. Hoyek (Beirut, Lebanon), N. Nassim (Beirut, Lebanon), G. Khayat (Beirut, Lebanon), G. Sleilaty (Beirut, Lebanon), M. Riachy (Beirut, Lebanon). Lactate dehydrogenase (LDH) reinforcement in predicting Covid-19 patient’s outcomes. 349
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|